JavaScript is used in a variety of ways to improve your browsing experience, such as validating and executing form submissions and allowing interactive content. Below, we have provided simple instructions for enabling JavaScript in the most popular web browsers. To...
GlaxoSmithKline has announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in the US, all...
A Wake Forest University study to investigate the effects of acute beetroot juice ingestion on the exercise capacity of COPD patients shows some promise, but a larger clinical trial is needed to verify results. The new research, published online ahead of print in the...
Posted Monday, January 26th 2015 @ 12pm A cheerleader on my team was diagnosed with a terminal illness and died and had her funeral exactly one year from the diagnosis.My grandpa was diagnosed with lung cancer, and he passed away within 2 month’s. He seemed...
Inside the GSK plant in Zebulon that will produce respiratory drugs including Arnuity and Incruse 15 photos Home of the Day Sponsor Listing Jason deBruyn Staff Writer- Triangle Business Journal GlaxoSmithKline (NYSE: GSK) commercially introduced two next-generation...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
